Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flamel Technologies SA (NASDAQ:FLML)

13.85
Delayed Data
As of Aug 24
 -1.04 / -6.98%
Today’s Change
7.56
Today|||52-Week Range
24.95
+13.43%
Year-to-Date
No recent news for Flamel Technologies SA.

Today’s Trading

Previous close14.89
Today’s open14.85
Day’s range13.57 - 15.45
Volume254,213
Average volume (3 months)211,116
Market cap$614.1M
Dividend yield--
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-122.22%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+1,084.01%
P/E ratio35.5
Price/Sales3.09
Price/Book9.05

Competitors

 Today’s
change
Today’s
% change
RPTPRaptor Pharmaceutica...-0.33-4.52%
CORTCorcept Therapeutics...-0.14-2.48%
AIMTAimmune Therapeutics...-0.34-2.24%
DVAXDynavax Technologies...-0.81-4.81%
Data as of 08/24/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$172.3M
Annual profit (last year)$40.4M
Net profit margin23.47%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Michael Shannon Anderson
Vice President-Supply Chain &
Operations
Scott A. Macke
Corporate headquarters
Vénissieux, Rhone-alpes

Forecasts

Partner Offers

Search for Jobs